Skip to content
Harbor Art Pro

Zimbabwe Declines ‘Lopsided’ American Healthcare Assistance Package Because of Data Fears

Health funding image
The proposed US financial assistance was intended for initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a significant American health deal valued at $367m (£272m) spanning five years because of the United States' request for sensitive biological samples.

This move was revealed after a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".

A government spokesperson has since explained that the US was demanding access to biological samples for scientific study and profit but refused to share the resulting advantages from any future treatments.

"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for more talks to secure a deal acceptable to all parties so the nation's vital HIV programme can proceed.

Wider Background

This rejection follows a comparable case in Kenya, where a court blocked a related deal with the US after concerns were filed about the security of citizens' health data.

After returning to the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance transparency and accountability.

Based on statements, Sixteen African countries have so far agreed to these new agreements, constituting over $18.3bn in committed funds.

Details of the Declined Agreement

The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana said the proposed deal was "unfair".

"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no corresponding promise of access to any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.

"Put simply, our nation would supply the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our people if a new pandemic emerge."

National Interest and Global Health

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting structures already set up via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future global health emergencies.

"This mechanism is intended to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We encourage continued discussions with our US partners on how future collaboration might be designed in a way that respects the sovereignty and dignity of each country."

Health Experts Reaction

A leading public health body expressed it recognised the official position, but suggested that negotiations need to persist considering much of the country's Aids initiatives relied on foreign aid.

"In cases where technical issues arise, including those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and negotiated safeguards," the group commented.

The situation highlights the ongoing challenges between receiving crucial international aid and protecting local interests in an increasingly interconnected world.

SP
About the author

Scott Porter

Lena Visser is a Dutch visual artist with over a decade of experience in contemporary art and art education.

Harbor Art Pro

Type to search articles.